megestrol acetate mga sold brand name megace among others progestin medication used mainly appetite stimulant treat wasting syndromes also used treat breast cancer endometrial cancer used birth mga generally formulated alone although combined estrogens birth control usually taken side effects mga include increased appetite weight gain vaginal bleeding nausea edema low sex hormone levels sexual dysfunction osteoporosis cardiovascular complications glucocorticoid effects mga progestin synthetic progestogen hence agonist progesterone receptor biological target progestogens like weak partial androgenic activity weak glucocorticoid activity important hormonal due progestogenic activity mga antigonadotropic mechanism action appetite stimulant effects mga mga discovered introduced medical use specifically birth control pills may considered firstgeneration medication withdrawn countries due concerns mammary toxicity observed dogs turned apply mga approved treatment endometrial cancer wasting syndromes marketed widely throughout available generic bangladesh india megestrol marketed trade name megestol ziska pharmaceuticals mezest beacon pharmaceuticals trade name varigestrol laboratorio varifarma argentina mga used mainly appetite stimulant promote weight gain variety given high dosages substantially increase appetite individuals even advanced cancer often used boost appetite induce weight gain patients cancer hivaidsassociated addition effects appetite mga appears antiemetic mga also used antineoplastic agent treatment breast cancer endometrial significantly inferior aromatase inhibitors clinical effectiveness tolerability secondline therapy breast cancer tamoxifen mga formerly used combined oral contraceptives combination ethinylestradiol used combined injectable contraceptive combination estradiol although approved uses mga studied andor used offlabel variety indications including menopausal hormone treatment hot gynecologicalmenstrual endometrial ovarian prostate benign prostatic male breast precocious mga also used treat pattern hair loss men side effects generally make unacceptable appetite stimulation achieved mga oral dosages optimal dosage maximum effect appetite stimulation determined recommended oral dosage mga breast cancer mg four times per day mgday total medication used oral dosage mgday divided doses endometrial used far lower dosages eg mgday oral mgmonth imtooltip intramuscular injection combination estrogen contraceptive mga available mg mg mg oral tablets oral suspensions mgml mgml ml used doses mg mg mg mg combined oral mga formulated dose mg combination dose mg estradiol microcrystalline aqueous suspension use oncemonthly combined injectable contraceptive contraindications mga include hypersensitivity mga component formulation known suspected pregnancy mga teratogen animals may potential cause fetal harm decreased fetal weight feminization male common side effect mga weight gain incidence high dosages used treat breast side effects include vaginal bleeding nausea edema well others dizziness shortness mga cause hypogonadism associated symptoms like diminished secondary sexual characteristics sexual dysfunction osteoporosis reversible infertility men premenopausal combining mga androgenanabolic steroid like oxandrolone nandrolone decanoate testosterone men alleviate mgaassociated symptoms hypoandrogenism well increase appetite weight less common serious side effects mga include cardiovascularthromboembolic complications may also cause glucocorticoid side effects cushing syndromelike symptoms steroid diabetes adrenal insufficiency high case reports deep vein thrombosis pulmonary embolism jaundice intrahepatic cholestasis meningiomas association highdosage mga older patients take mga one adverse event leading mga studied high dosages much mgday serious adverse effects clear increase rate severity side effects observed mgday mga except weight gain mild increases blood pressure fluid postmarketing experience limited reports overdose signs symptoms described reports included diarrhea nausea abdominal pain shortness breath cough unsteady gait listlessness chest specific antidote overdose treatment supportive based mga assessed however due low solubility thought dialysis would useful treating mga interactions mga include significantly decreased exposure indinavir may necessitate increased dosage mga coadministered zidovudine rifabutin significant change exposure medications dosage adjustment mga progestogenic activity antigonadotropic effects weak partial androgenic activity weak glucocorticoid mga progestogen agonist progesterone receptor affinity promegestone affinity progesterone like progestogens mga functional antiestrogenic effects certain tissues endometrium antigonadotropic total endometrial transformation dose mga mg per mga antigonadotropic effects humans sufficient doses capable profoundly suppressing circulating androgen estrogen antigonadotropic effects mga result activation pr suppresses secretion hormones responsible signaling body produce progesterone also androgens pituitary gland form negative feedback inhibition hence downregulates axis hpg axis resulting decreased levels sex hormones interference mga functional antiandrogenic antiestrogenic effects well contraceptive effects via antigonadotropic precise ovulationinhibiting dosage mga however doses mg mga previously used combined birth control pills combination estrogen ethinylestradiol mga effective contraceptive dosages mgday effective dosage mga alone inhibit ovulation dosage mgday fully inhibit ovulation dosage mgday even dosage combination mgday mga μgday mestranol found consistently inhibit ovulation whereas either medication alone completely inhibit ovulation suppression testosterone levels mga responsible effectiveness treatment conditions like prostate cancer benign prostatic one study mgday mga suppressed testosterone levels men however recovery escape testosterone levels gradually returning nearnormal values observed men months mga therapy limited usefulness combination lower dosage mga mgday low oral dosage estrogen estradiol mgday diethylstilbestrol mgday ethinylestradiol µgday able suppress testosterone levels castrate range men maintain suppression longterm achieve equivalent effectiveness highdosage estrogen monotherapy treatment prostate cancer comparatively greatly reduced toxicity side spite results however combination rarely used treat prostate cancer united antigonadotropic well anticorticotropic effects mga may involved effectiveness treatment postmenopausal breast cancer via substantially decreasing gonadal adrenal production sex steroids extension circulating levels estrogens mga weak partial agonist androgen receptor reported bind receptor affinity anabolic steroid despite weak intrinsic activity ar clinical doses humans mga appears behave intents purposes purely based fact virilizing side effects observed use mga patients either sex dosages high mg per day highest furthermore mga produces detectable androgenic effects animals dose equivalent approximately times typically used treatment prostate cancer however medication moderate androgenic effects serum lipids humans causing significant reduction hdl ldl cholesterol levels change triglyceride levels dosage conversely mga decrease shbg weak significant androgenic activity mga may serve limit clinical effectiveness treatment prostate mga agonist glucocorticoid receptor gr biological target glucocorticoids like found possess affinity corticosteroid dexamethasone mga shows lowest ratio pr affinity gr affinity broad selection marketed progestins suggesting may among highest relative glucocorticoid effect progestins used mga produces observable glucocorticoid effects one study finding dose range tested possessed eosinopenic hyperglycemic activity markers glucocorticoid activity equal amount medroxyprogesterone acetate accordingly manifestations glucocorticoid activity including symptoms cushings syndrome steroid diabetes adrenal insufficiency reported use mga literature albeit mga frequently used appetite stimulant promote weight direct mechanism appetite enhancement unclear known mga induces variety downstream changes cause effect including stimulation release neuropeptide hypothalamus neurosteroidlike modulation calcium channels ventromedial inhibition secretion proinflammatory cytokines including interleukin interleukin interleukin tumor necrosis factor α implicated facilitation increased levels insulinlike growth factor may also involved specifically anabolic studies mga elderly patients experience weight loss limited poor quality showing minimal weight gain nutritional clinically significant beneficial outcomes observed patients take mga one increase unlike case ar mga significant affinity possess capacity directly activate furthermore unlike antiandrogens spironolactone bicalutamide similarly cyproterone acetate relatively little risk indirectly mediated estrogenic side effects eg gynecomastia mga strongly suppresses androgen estrogen levels similarly case er mga negligible affinity mineralocorticoid receptor mr hence possess mineralocorticoid antimineralocorticoid mga found dosedependently increase total free levels dosage total levels described profoundly increased gradually increasing significantly days treatment maximum months free readily dissociable concentrations increased smaller extent described increasing suggested increase levels highdosage mga therapy may explain anabolic effects mga patients oral bioavailability mga approximately single low oral dose mg mga peak serum concentrations mga ngdl nmoll occurred following single high oral dose mg micronized mga men peak circulating levels mga ngml nmoll occurred study found micronized mga dose showed considerably improved absorption relative conventional tablet terms plasma protein binding mga bound mostly albumin bound sex hormonebinding globulin corticosteroidbinding mga metabolized liver mainly hydroxylation positions well reduction elimination halflife hours average range mga excreted urine high doses mga appears far greater bioavailability potency medroxyprogesterone acetate regardless whether route administration latter oral following oral administration mg mga mg medroxyprogesterone acetate circulating levels mga higher medroxyprogesterone similar findings found oral mga relative medroxyprogesterone acetate administered via intramuscular mga also reaches steadystate levels quickly medroxyprogesterone improved potency mga compared medroxyprogesterone acetate may due increased resistance metabolism mga afforded double bond medroxyprogesterone acetate identical mga structure except lacking pharmacokinetics mga mga also known synthetic pregnane steroid derivative specifically derivative methyl group position double bond positions acetate ester mga acetate ester megestrol contrast mga never analogues mga include derivatives acetomepregenol anagestone acetate chlormadinone acetate cyproterone acetate hydroxyprogesterone caproate medroxyprogesterone acetate nomegestrol mga differs medroxyprogesterone acetate double close analogues mga never marketed include cymegesolate megestrol acetate megestrol chemical syntheses mga mga synthesized syntex derived medroxyprogesterone acetate synthesized syntex mga third synthetic derivative progesterone developed use medication following hydroxyprogesterone caproate medroxyprogesterone acetate medication introduced medical use combination ethinylestradiol ee oral contraceptive british drug houses united kingdom brand name volidan mg mga μg ee followed serial mg mga μg ee tablets volidan mg mga μg ee tablets nuvacon mg mga μg ee tablets british drug houses also united also marketed brand name delpregnin mg mga μg mestranol tablets among mgacontaining birth control pills withdrawn reports early high incidence venous thromboembolism early mga found associated mammary tumors beagle dogs along several progestogens withdrawn oral contraceptive several markets including united kingdom canada west also investigation use contraceptive united states development discontinued following mammary toxicity findings dogs mga never marketed oral contraceptive united subsequent research monkey studies revealed similar risk following withdrawal market mga eventually reintroduced treatment hormonesensitive addition mga marketed veterinary use dogs united kingdom united progesterone first found effective treatment endometrial hyperplasia progestins first found effective treatment endometrial cancer mga reported effective treatment endometrial hyperplasia first started studied treatment endometrial cancer findings published mga reportedly introduced treatment endometrial cancer united states progesterone studied treatment breast cancer relatively modest mga first studied treatment breast cancer one first progestins evaluated treatment second study conducted breakthrough surge interest progestins breast cancer occurred study using massive dosage medroxyprogesterone acetate treat breast cancer third study mga breast cancer published followed additional studies mga approved treatment breast cancer united states least progestogens including progesterone ethisterone studied treatment prostate cancer mga first studied treatment prostate cancer additional studies conducted followed others however results mga therapy prostate cancer medication approved treatment prostate cancer united states clinical studies high dosages mga breast cancer conducted observed markedly increased appetite weight gain treated patients despite advanced led potential interest mga appetite paper published proposing study potential use mga mga subsequently studied following completion phase iii clinical trials approved oral suspension treatment syndrome due cancer chronic conditions hivaids united states thereafter branded product megace es heavily promoted maker par pharmaceutical treatment unintentional weight loss elderly patients especially living longterm care facilities march par settled million federal multistate criminal civil lawsuit company accused promoting branded version mga generic version use treating nonaidsrelated geriatric wasting use approved safe effective food drug administration fda covered federal health care programs lawsuit claimed par marketed product effective use despite conducted wellcontrolled studies support claim greater efficacy megace es prior knowledge severe adverse side effects geriatric patients including deep vein thrombosis toxic reactions impaired renal function megestrol acetate generic name drug innmtooltip international nonproprietary name usantooltip united states adopted name usptooltip united states pharmacopeia banmtooltip british approved name megestrol inntooltip international nonproprietary name bantooltip british approved name mégestrol dcftooltip dénomination commune française megestrol free alcohol form medication also known developmental code names mga marketed variety brand names throughout world commonly sold brand name also available brand name megace es united states brand name megace os use veterinary medicine mga sold ovaban united states ovarid united mga available widely throughout world including united states canada united kingdom ireland elsewhere throughout europe australia new zealand latin america asia african appear marketed germany russia south africa japan india mexico among progestins birth control pills sometimes grouped progestins consistently grouped generations pregnane progestins used birth control pills typically omitted classifications grouped simply miscellaneous case based date introduction formulations mga could considered firstgeneration mga studied men combination testosterone male hormonal contraceptive suppress mga used veterinary medicine brand name ovaban treatment medical conditions cats due ability suppress testosterone levels mga control sexually dimorphic traits result mga used reduce dominance intermale aggression mounting urine spraying roaming male dogs httpsenwikipediaorgwikimegestrolacetate